Skip to main content

Rheumatoid Arthritis: Tuberculosis Screening (Recommended for eMeasure Trial Approval)

CBE ID
2522
Project
Primary Care and Chronic Illness
Endorsed
New or Maintenance
Maintenance
Endorsement and Maintenance (E&M) Cycle
Spring 2019
Is Under Review
No
Measure Description

Percentage of patients 18 years and older with a diagnosis of rheumatoid arthritis who have documentation of a tuberculosis (TB) screening performed within 6 months prior to receiving a first course of therapy using a biologic disease-modifying anti-rheumatic drug (DMARD).

  • Measure Type
    Process
    Electronic Clinical Quality Measure (eCQM)
    No
    Level Of Analysis
    Clinician: Group/Practice
    Clinician: Individual
    Care Setting
    Outpatient Services
    Numerator

    Any record of TB testing documented or performed (PPD, IFN-gamma release assays, or other appropriate method) in the medical record in the 12 months preceding the biologic DMARD prescription.

    Denominator

    Patients 18 years and older with a diagnosis of rheumatoid arthritis who are seen for at least one face-to-face encounter for RA who are newly started on biologic therapy during the measurement period.

    Exclusions

    N/A

    Testing Data Sources
    Electronic Health Records: Electronic Health Records
    Registry data
  • Most Recent Endorsement Activity
    Approved for Trial Use Primary Care and Chronic Illness Spring Cycle 2019
    Initial Endorsement
    Next Planned Maintenance Review
    Primary Care and Chronic Illness Fall 2023
    Endorsement Status
    Approved for Trial Use
    Last Updated